Frontlight ResearchEarly access
Trial site
Het Van Weel-Bethesda Ziekenhuis
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Atrial fibrillation2 trials
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Hypothyroidism1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Obesity1 trial
- Triple-negative breast cancer1 trial
- Type 1 diabetes1 trial
- and 1 more
- Phase
- Phase 314 trials
- Phase 41 trial
- Status
- Recruiting7 trials
- Completed5 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Ionis Pharmaceuticals, Inc.3 trials
- Eli Lilly and Company2 trials
- Amgen1 trial
- Bayer AG1 trial
- Erasmus Medical Center1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Heart failure1 recruiting
- Hypothyroidism1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Obesity1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026